Hsi-Chung Chen1, Tung-Ping Su, Pesus Chou. 1. Department of Psychiatry & Center of Sleep Disorders, National Taiwan University Hospital, Taipei, Taiwan.
Abstract
STUDY OBJECTIVES: To simultaneously explore the associations between mortality and insomnia, sleep duration, and the use of hypnotics in older adults. DESIGN: A fixed cohort study. SETTING: A community in Shih-Pai area, Taipei, Taiwan. PARTICIPANTS: A total of 4,064 participants over the age of 65 completed the study. INTERVENTION: N/A. MEASUREMENTS AND RESULTS: Insomnia was classified using an exclusionary hierarchical algorithm, which categorized insomnia as "no insomnia," "subjective poor sleep quality," "Pittsburgh Sleep Quality Index > 5 insomnia," "1-month insomnia disorder," and "6-month insomnia disorder." The main outcome variables were 9-year all-cause mortality rates. In the all-cause mortality analyses, when hypnotic use, depressive symptoms and total sleep time were excluded from a proportional hazards regression model, subjects with "Pittsburgh Sleep Quality Index > 5 insomnia" had a higher mortality risk (HR: 1.21, 95% CI: 1.01-1.45). In the full model, frequent hypnotic use and long sleep duration predicted higher mortality rates. However, the increased mortality risk for subjects with "Pittsburgh Sleep Quality Index > 5 insomnia" was not observed in the full model. On the contrary, individuals with a 6-month DSM-IV insomnia disorder had a lower risk for premature death (HR: 0.64, 95% CI: 0.43-0.96). CONCLUSIONS: Long sleep duration and frequent hypnotics use predicted an increased mortality risk within a community-dwelling sample of older adults. The association between insomnia and mortality was affected by insomnia definition and other parameters related to sleep patterns.
STUDY OBJECTIVES: To simultaneously explore the associations between mortality and insomnia, sleep duration, and the use of hypnotics in older adults. DESIGN: A fixed cohort study. SETTING: A community in Shih-Pai area, Taipei, Taiwan. PARTICIPANTS: A total of 4,064 participants over the age of 65 completed the study. INTERVENTION: N/A. MEASUREMENTS AND RESULTS:Insomnia was classified using an exclusionary hierarchical algorithm, which categorized insomnia as "no insomnia," "subjective poor sleep quality," "Pittsburgh Sleep Quality Index > 5 insomnia," "1-month insomnia disorder," and "6-month insomnia disorder." The main outcome variables were 9-year all-cause mortality rates. In the all-cause mortality analyses, when hypnotic use, depressive symptoms and total sleep time were excluded from a proportional hazards regression model, subjects with "Pittsburgh Sleep Quality Index > 5 insomnia" had a higher mortality risk (HR: 1.21, 95% CI: 1.01-1.45). In the full model, frequent hypnotic use and long sleep duration predicted higher mortality rates. However, the increased mortality risk for subjects with "Pittsburgh Sleep Quality Index > 5 insomnia" was not observed in the full model. On the contrary, individuals with a 6-month DSM-IV insomnia disorder had a lower risk for premature death (HR: 0.64, 95% CI: 0.43-0.96). CONCLUSIONS: Long sleep duration and frequent hypnotics use predicted an increased mortality risk within a community-dwelling sample of older adults. The association between insomnia and mortality was affected by insomnia definition and other parameters related to sleep patterns.
Entities:
Keywords:
Insomnia; older adults; sleep duration; sleep pattern; use of hypnotics
Authors: Henry C Driscoll; Linda Serody; Susan Patrick; Jennifer Maurer; Salem Bensasi; Patricia R Houck; Sati Mazumdar; Eric A Nofzinger; Bethany Bell; Robert D Nebes; Mark D Miller; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2007-12-10 Impact factor: 4.105
Authors: Mary Amanda Dew; Carolyn C Hoch; Daniel J Buysse; Timothy H Monk; Amy E Begley; Patricia R Houck; Martica Hall; David J Kupfer; Charles F Reynolds Journal: Psychosom Med Date: 2003 Jan-Feb Impact factor: 4.312
Authors: Sanjay R Patel; Najib T Ayas; Mark R Malhotra; David P White; Eva S Schernhammer; Frank E Speizer; Meir J Stampfer; Frank B Hu Journal: Sleep Date: 2004-05-01 Impact factor: 5.849
Authors: Nathaniel F Watson; M Safwan Badr; Gregory Belenky; Donald L Bliwise; Orfeu M Buxton; Daniel Buysse; David F Dinges; James Gangwisch; Michael A Grandner; Clete Kushida; Raman K Malhotra; Jennifer L Martin; Sanjay R Patel; Stuart F Quan; Esra Tasali Journal: J Clin Sleep Med Date: 2015-08-15 Impact factor: 4.062
Authors: Nathaniel F Watson; M Safwan Badr; Gregory Belenky; Donald L Bliwise; Orfeu M Buxton; Daniel Buysse; David F Dinges; James Gangwisch; Michael A Grandner; Clete Kushida; Raman K Malhotra; Jennifer L Martin; Sanjay R Patel; Stuart F Quan; Esra Tasali Journal: Sleep Date: 2015-08-01 Impact factor: 5.849
Authors: Hind A Beydoun; May A Beydoun; Xiaoli Chen; Jen Jen Chang; Alyssa A Gamaldo; Shaker M Eid; Alan B Zonderman Journal: Sleep Med Date: 2017-05-29 Impact factor: 3.492
Authors: Laura Q Rogers; Kerry S Courneya; Robert A Oster; Philip M Anton; Randall S Robbs; Andres Forero; Edward McAuley Journal: Med Sci Sports Exerc Date: 2017-10 Impact factor: 5.411